Axogen, Inc. (AXGN) Financial Statements (2025 and earlier)

Company Profile

Business Address 13631 PROGRESS BLVD.
ALACHUA, FL 32615
State of Incorp. MN
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments33,48231,02448,78984,086103,96696,510
Cash and cash equivalent27,55431,02415,28432,75648,76735,724
Short-term investments5,928 33,50551,33055,19960,786
Receivables24,10525,14722,18618,18117,64116,944
Inventory, net of allowances, customer advances and progress billings33,18323,02018,90516,69312,52913,861
Inventory33,18323,02018,90516,69312,52913,861
Prepaid expense    1,3593,597 
Other undisclosed current assets8,4478,8138,1956,7307,5187,706
Total current assets:99,21788,00498,075127,049145,251135,021
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization372841426487
Operating lease, right-of-use asset14,26515,56214,36915,19315,6143,133
Property, plant and equipment    62,88138,39814,887
Intangible assets, net (including goodwill)5,5794,5313,6492,8592,0541,515
Intangible assets, net (excluding goodwill)5,5794,5313,6492,8592,0541,515
Other undisclosed noncurrent assets84,63088,70279,253   
Total noncurrent assets:104,511108,82397,31280,97556,13019,622
TOTAL ASSETS:203,728196,827195,387208,024201,381154,643
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28,64128,88322,44322,45921,96819,130
Employee-related liabilities9,67313,5937,631
Accounts payable 8,00811,7748,9645,9234,5978,262
Accrued liabilities 20,63317,10913,4796,8633,7783,237
Other undisclosed accounts payable and accrued liabilities      
Deferred revenue    141414
Debt9679171,736
Other undisclosed current liabilities1,9601,5411,3031,811832 
Total current liabilities:30,61030,43023,75324,29322,83120,880
Noncurrent Liabilities
Long-term debt and lease obligation47,52646,62245,73065,61932,0271,595
Long-term debt, excluding current maturities47,49646,60345,71244,82132,0271,595
Finance lease, liability3019184  
Liabilities, other than long-term debt21,68524,11024,9055,5622,50015
Deferred revenue      15
Other liabilities94   3 
Operating lease, liability19,19121,12320,38720,794  
Derivative instruments and hedges, liabilities2,4002,9874,5185,5622,497 
Other undisclosed noncurrent liabilities     20,874 
Total noncurrent liabilities:69,21170,73270,63571,18155,4011,610
Total liabilities:99,821101,16294,38895,47478,23222,490
Equity
Equity, attributable to parent103,90795,665100,999112,550123,149132,153
Common stock441431424417406396
Additional paid in capital394,726376,530360,155342,765326,390311,618
Accumulated deficit(291,260)(281,296)(259,580)(230,632)(203,647)(179,861)
Total equity:103,90795,665100,999112,550123,149132,153
TOTAL LIABILITIES AND EQUITY:203,728196,827195,387208,024201,381154,643

Income Statement (P&L) ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues187,338159,012138,584127,358112,300106,712
Cost of revenue
(Cost of Product and Service Sold)
(45,361)(31,138)(24,147)(22,931)(21,581)(17,349)
Gross profit:141,977127,874114,437104,42790,71989,363
Operating expenses(145,264)(149,336)(144,144)(129,843)(113,901)(120,769)
Operating income (loss):(3,287)(21,462)(29,707)(25,416)(23,182)(31,406)
Nonoperating income (expense)(6,677)(254)759(1,569)(604)2,271
Investment income, nonoperating1,1411,487569654882,364
Other nonoperating income (expense)(199)(437)(230)(278)(38)(53)
Interest and debt expense(8,206)(2,835)(624)(1,356)(1,054)(40)
Loss from continuing operations:(18,170)(24,551)(29,572)(28,341)(24,840)(29,175)
Loss before gain (loss) on sale of properties:(28,341)(24,840)(29,175)
Net loss:(18,170)(24,551)(29,572)(28,341)(24,840)(29,175)
Other undisclosed net income attributable to parent8,2062,8356241,3561,05440
Net loss available to common stockholders, diluted:(9,964)(21,716)(28,948)(26,985)(23,786)(29,135)

Comprehensive Income ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(18,170)(24,551)(29,572)(28,341)(24,840)(29,175)
Comprehensive loss, net of tax, attributable to parent:(18,170)(24,551)(29,572)(28,341)(24,840)(29,175)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: